Willie Loh - 25 May 2023 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 25 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 May 2023, 16:43:16 UTC
Prior SEC filing: 06 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ Charles B. Haaser, attorney-in-Fact

Key filing fact

Willie Loh filed Form 4 for YIELD10 BIOSCIENCE, INC. on 30 May 2023.

Key facts

This page summarizes Willie Loh's Form 4 filing for YIELD10 BIOSCIENCE, INC..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 30 May 2023, 16:43.

Change

Previous filing in this sequence was filed on 06 Oct 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

YTEN transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +5,000
Change %
Price: $0.000000
Shares after: 5,000
Date: 25 May 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price: $2.81
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These options will vest and become exercisable in equal quarterly installments over 4 years from 5/25/2023, beginning on 8/25/2023 and ending on 5/25/2027.

Footnote F2

These options were granted to the Reporting Person as the annual option grant to non-employee directors pursuant to the Issuer's Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors.